The Global Avascular Necrosis Market size Accounted for USD 611 Million in 2021 and is predicted to be worth USD 1,026 Million by 2030, with a CAGR of 6.1% during the forthcoming period from 2022 to 2030.
The increasing number of fatal crashes and physical trauma is a primary driving the avascular necrosis market growth. Increased alcohol consumption and excessive corticosteroid usage are expected to drive market growth over the next few years. Similarly, the growing popularity of advanced minimally invasive medical therapy is expected to enhance the avascular necrosis market value. As a result of these factors, the global avascular necrosis market trend is likely to rise steadily in terms of revenue throughout the forecast period.
Avascular necrosis also referred to as osteonecrosis, is the fatal of bone tissue as a result of a loss of blood flow, which can result in microscopic cracks in the bones and final collapse. Although the pathophysiology of avascular necrosis is unknown, it is believed to be a multi-factorial disease, with people with the disease reporting visibility to one or even more risk variables such as corticosteroid use, alcohol abuse, hip trauma, HIV, caisson disease, hemoglobinopathies, chemotherapy, and pregnancy. Avascular necrosis develops when blood supply to bones is blocked or diminished, which can happen as a result of joint or bone damage, internal tissues in blood vessels, or certain disorders. In the initial stages of avascular necrosis, most persons experience no symptoms. As the situation deteriorates, the affected joint may ache and feel discomfort, which could be slight or severe, and normally plan is developed. The advancement of avascular necrosis can be slowed using bone grafting, osteotomy, core decompression, as well as other medical procedures.
Global Avascular Necrosis Market DRO’s
Avascular Necrosis Market Report Coverage
|Market||Avascular Necrosis Market|
|Avascular Necrosis Market Size 2021||USD 611 Million|
|Avascular Necrosis Market Forecast 2030||USD 1,026 Million|
|Avascular Necrosis Market CAGR||6.1% During 2022 - 2030|
|Analysis Period||2018 - 2030|
|Forecast Data||2022 - 2030|
|Segments Covered||By Disease Type, By Treatment Type, By Sales Channel, And By Region
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||Teva Pharmaceuticals Industries Ltd., GSK, Pfizer, Inc., Reddy’s Laboratories Ltd., Bayer AG, Alkem Labs, Novartis AG, Solara Active Pharma Sciences Limited., Rochem International, Inc., and Dwarkesh Pharmaceuticals Private Limited.|
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
Avascular Necrosis Market Dynamics
The expanding geriatric population raises the prevalence of avascular necrosis globally, as well as the growing desire for non-invasive intervention in addition to technical improvements for improved osteonecrosis treatment, are the primary major factors in the avascular necrosis market value. The growing incidences of osteonecrosis worldwide, as well as the increasing need for non-invasive therapy and reliance on operations to cure avascular necrosis, are likely to accelerate market expansion. Furthermore, the growing prevalence of the non-invasive approach to avascular necrosis hospitalization will pave the road for market expansion. Besides that, the prevalence of osteonecrosis is rising as a result of some of the common causes of the disease. As a result, the desire for osteonecrosis therapy is increasing, and the avascular necrosis market is expected to rise exponentially throughout the projected timeframe.
Furthermore, the rise in global alcohol use is a major factor driving the growth of the avascular necrosis market. According to a survey conducted by the National Institute on Alcohol Abuse and Alcoholism, the number of people drinking alcohol in the United States has grown tremendously in recent years. According to the avascular necrosis industry analysis, the proportion of female alcohol consumers has more than doubled. Alcohol misuse causes aberrant lipid metabolism, which is a substantial risk factor for alcohol-induced avascular necrosis, resulting in a surge of avascular necrosis market major trends and prospects.
Avascular Necrosis Market Segmentation
The global avascular necrosis market segmentation is based on the disease type, treatment type, sales channel, and geographical region.
Market by Disease Type
In terms of disease type, the non-traumatic avascular necrosis segment is predicted to capture a significant share of the avascular necrosis market. These rises are the result of metabolic bone diseases, increased consumption of alcohol, metabolic bone diseases, and other ailments. Non-traumatic avascular necrosis of the femoral head is the major cause of impairment in young folks, resulting in significant health care costs. The growing usage of testosterone and alcohol intake in the latest days has considerably increased the frequency of femoral head necrosis.
Market by Treatment Type
In terms of treatment type, the cholesterol-lowering drugs segment held the largest market share in 2021. This growth is related to the fact that lowering the quantity of cholesterol as well as fat within circulation may help avoid arterial obstructions that might contribute to avascular necrosis. Besides that, the nonsteroidal anti-inflammatory drugs segment is predicted to rise at a significant rate in the market over the next few years. These medications aid in the relief of pain associated with Avascular Necrosis of the Hip. Furthermore, this sector is subdivided into ibuprofen and naproxen sodium.
Market by Sales Channel
According to the avascular necrosis market forecast, the hospital pharmacy segment is expected to increase significantly in the approaching years. The increasing demand for non-invasive treatment and reliance on surgery to cure osteonecrosis is driving segment expansion. Furthermore, improving healthcare infrastructure by regional governments, as well as rising hospitalization choices, is propelling the market forward.
Avascular Necrosis Market Regional Outlook
The Middle East & Africa (MEA)
North America to Hold a Substantial Market Share in Avascular necrosis Market
North America is said to be significantly responsible for revenue shares, accounting for more than one-third of the worldwide avascular necrosis market, due to its higher acceptance of cutting-edge therapeutic approaches and greater concentration of relevance of avascular necrosis in individuals. In this region, the United States has seen a greater acceptance of avascular necrosis approach. The growing senior population, together with the public emphasis on the medical problem and diagnostics in this region, is expected to propel the expansion of the avascular necrosis market. Moreover, North America is projected to dominate the avascular necrosis market owing to the growing number of aggressive investment tactics adopted by industry participants.
Avascular Necrosis Market Players
Some of the prominent global avascular necrosis market companies are Teva Pharmaceuticals Industries Ltd., GSK, Pfizer, Inc., Reddy’s Laboratories Ltd., Bayer AG, Alkem Labs, Novartis AG, Solara Active Pharma Sciences Limited., Rochem International, Inc., and Dwarkesh Pharmaceuticals Private Limited.
The global avascular necrosis market size in 2021 was accounted to be USD 611 Million.
The projected CAGR of avascular necrosis during the analysis period of 2022 to 2030 is 6.1%
The prominent players of the global avascular necrosis market involve Teva Pharmaceuticals Industries Ltd., GSK, Pfizer, Inc., Reddy’s Laboratories Ltd., Bayer AG, Alkem Labs, Novartis AG, Solara Active Pharma Sciences Limited., Rochem International, Inc., and Dwarkesh Pharmaceuticals Private Limited.
North America held the dominating share for avascular necrosis during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for avascular necrosis during the analysis period of 2022 to 2030.
Rising incidence of osteonecrosis globally and growing acceptance for non-invasive treatment are the prominent factors that fuel the growth of global avascular necrosis market.
Based on treatment type, cholesterol lowing drugs segment holds the maximum share for avascular necrosis market in 2021.